Richard M. Dubinsky, MD

Professional Background

Richard Dubinsky, M.D., MPH, is a graduate of the six-year B.A./M.D. program at the University of Missouri-Kansas City School of Medicine. He received his bachelor's degree in history and biology in 1981 and his medical degree in 1982. He completed an internship in internal medicine at Baylor College of Medicine, Houston, Texas, followed by a neurology residency at the Baylor College of Medicine. Following his residency, Dr. Dubinsky served a two-year fellowship in human motor control under the auspices of Mark Hallet, M.D., in the Clinical Neurology Branch of the National Institute of Neurological, Communicative Disorders and Strokes, National Institutes of Health, Bethesda, Maryland. After this fellowship, he joined the faculty of the University of Kansas Medical Center and founded the Dystonia Clinic.

Dr. Dubinsky is board certified in adult neurology by the American Board of Psychiatry and Neurology with added qualifications in clinical neurophysiology. He is also certified by the American Board of Electrodiagnostic Medicine. A Fellow of the American Academy of Neurology (AAN), Dr. Dubinsky has served on the professional organization’s Quality Standards subcommittee and the Technology and Therapeutics Assessment committee. He also was chair of the Practice Improvement and vice-chair of the Quality Measures Reporting subcommittees of the AAN. Based upon his work for the AAN, he returned to graduate school in 2001, receiving his MPH from KU in 2004.

Dr. Dubinsky's clinical interests include the treatment of movement disorders, specifically dystonia, myoclonus, Huntington's Disease, and other movement disorders as well as Parkinson' Disease. One of his more unusual clinical activities is serving as the consulting neurologist for the Kansas City Zoological Gardens in Kansas City, Missouri.

Previously, he served as the program director of the neurology residency program (1992-1997, 2008-2019), associate program director of the clinical neurophysiology fellowship (2001-2003), director of the clinical neurophysiology fellowship program (2003-2007) and associate director of the Neurology residency program (2005-2007).

• BA, Biology and History, Univ. of Missouri-Kansas City
• MD, Univ. of Missouri-Kansas City
• MPH, Univ. of Kansas-Medical Ctr.
• Other, Baylor College of Medicine, Houston, TX
• Other, Baylor College of Medicine, Houston, TX
• Other, Motor Control Fellowship under Mark Hallett, MD, National Institute of Neurological, Communicative Disorders and Stroke, National Institutes of Health, Bethesda, MD

• Kansas Medical License, Kansas Board of Healing Arts
• Neurology, American Board of Psychiatry and Neurology

• Promotion and Tenure Committee, Department of Neurology, Promotion and Tenure Committee, Department of Neurology, Other, 2020 - Present
• Data Safety Monitoring Board (DSMB) Trial of Oxaloacetate in Alzheimer's Disease (TOAD) IND#125788, Swerdlow, R, Principal Investigator, Data Safety Monitoring Board (DSMB) Trial of Oxaloacetate in Alzheimer's Disease (TOAD) IND#125788, Swerdlow, R, Principal Investigator, Other, 2016 - Present
• Data Safety Monitoring Board (DSMB) Trial of Exercise on Aging and Memory (TEAM), Burns, J Principal Investigator and Alzheimer's Disease Exercise Program Clinical Trial (ADEPT), Burns, J Principal Investigator, Data Safety Monitoring Board (DSMB) Trial of Exercise on Aging and Memory (TEAM), Burns, J Principal Investigator and Alzheimer's Disease Exercise Program Clinical Trial (ADEPT), Burns, J Principal Investigator, Other, 2011 - Present
• Executive Committee, Department of Neurology, Executive Committee, Department of Neurology, Other, 2008 - Present
• Graduate Medical Education Committee, Graduate Medical Education Committee, Other, 2003 - Present
• Dystonia Study Group, Member, 2000 - Present

---

Research

Overview

Dr. Dubinsky has published research in the areas of neurophysiology, PET scanning, treatment of movement disorders, evidence-based medicine and neuro-epidemiology. He also was one of the early investigators studying the use of botulinum and neurotoxins for the treatment of movement disorders. Dr. Dubinsky also is actively involved in clinical research in Huntington's disease, Parkinson's disease, and in dystonia.